QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

doi: 10.1242/10.1242/jcs.00146

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grewal, S. Articles by Walker, J. H. Search for Related Content PubMed PubMed Citation Articles by Grewal, S. Articles by Walker, J. H.

Nuclear localisation of cytosolic phospholipase A₂- in the EA.hy.926 human endothelial cell line is proliferation dependent and modulated by phosphorylation

¹ School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK
² Cancer Research UK Clinical Centre, St. James' Hospital, University of Leeds, Leeds, LS9 7TF, UK

^* Author for correspondence (e-mail: j.h.walker{at}leeds.ac.uk)

Accepted 4 September 2002

Cytosolic phospholipase A₂- (cPLA₂-) is a calcium-sensitive enzyme involved in receptor-mediated eicosanoid production. In resting cells, cPLA₂- is present in the cytosol and nucleus and translocates to membranes via its calcium-dependent lipid-binding (CaLB) domain following stimulation. cPLA₂- is also regulated by phosphorylation on several residues, which results in enhanced arachidonic acid release. Little is known about the factors controlling the nuclear localisation of cPLA₂-. Here the nuclear localisation of cPLA₂- in the EA.hy.926 human endothelial cell line was investigated. Nuclear localisation was dependent on proliferation, with subconfluent cells containing higher levels of nuclear cPLA₂- than contact-inhibited confluent or serum-starved cells. The broad-range protein kinase inhibitor staurosporine caused a decrease in the nuclear level of cPLA₂-, whereas the protein phosphatase inhibitor okadaic acid increased the level of nuclear cPLA₂-. Using inhibitors for specific mitogen-activated protein (MAP) kinases, both p42/44^MAPK and p38^MAPK were shown to be important in modulating nuclear localisation. Finally, inhibition of nuclear import and export using Agaricus bisporus lectin and leptomycin B, respectively, demonstrated that cPLA₂- contains functional nuclear localisation and export signals. Thus we have identified a novel mode of regulation of cPLA₂-. This, together with the increasing body of evidence supporting the role of nuclear lipid second messengers in gene expression and proliferation, may have important implications for controlling the growth of endothelial cells in angiogenesis and tumour progression.

Key words: Nucleus, Endothelial, EA.hy.926, Cytosolic phospholipase A₂-

This article has been cited by other articles:

				S. P. Herbert, A. F. Odell, S. Ponnambalam, and J. H. Walker The Confluence-dependent Interaction of Cytosolic Phospholipase A2-{alpha} with Annexin A1 Regulates Endothelial Cell Prostaglandin E2 Generation J. Biol. Chem., November 23, 2007; 282(47): 34468 - 34478. [Abstract] [Full Text] [PDF]

				L. Parhamifar, B. Jeppsson, and A. Sjolander Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells Carcinogenesis, November 1, 2005; 26(11): 1988 - 1998. [Abstract] [Full Text] [PDF]

				S. P. Herbert, S. Ponnambalam, and J. H. Walker Cytosolic Phospholipase A2-{alpha} Mediates Endothelial Cell Proliferation and Is Inactivated by Association with the Golgi Apparatus Mol. Biol. Cell, August 1, 2005; 16(8): 3800 - 3809. [Abstract] [Full Text] [PDF]

				J. N.M. Ilsley, M. Nakanishi, C. Flynn, G. S. Belinsky, S. De Guise, J. N. Adib, R. T. Dobrowsky, J. V. Bonventre, and D. W. Rosenberg Cytoplasmic Phospholipase A2 Deletion Enhances Colon Tumorigenesis Cancer Res., April 1, 2005; 65(7): 2636 - 2643. [Abstract] [Full Text] [PDF]

				B. C. Harrison, C. R. Roberts, D. B. Hood, M. Sweeney, J. M. Gould, E. W. Bush, and T. A. McKinsey The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression Mol. Cell. Biol., December 15, 2004; 24(24): 10636 - 10649. [Abstract] [Full Text] [PDF]

				N. Fernandez, M. Renedo, S. Alonso, and M. S. Crespo Release of Arachidonic Acid by Stimulation of Opsonic Receptors in Human Monocytes: THE Fc{gamma}R AND THE COMPLEMENT RECEPTOR 3 PATHWAYS J. Biol. Chem., December 26, 2003; 278(52): 52179 - 52187. [Abstract] [Full Text] [PDF]